Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan

• Haruka Shida,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Maki Komamine,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Kazuhiro Kajiyama,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Takashi Waki,

  Roles Methodology, Writing – original draft, Writing – review & editing

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Hotaka Maruyama,

  Roles Methodology, Writing – original draft, Writing – review & editing

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  ⨯
• Yoshiaki Uyama

  Roles Conceptualization, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: uyama-yoshiaki@pmda.go.jp

  Affiliation Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

  https://orcid.org/0000-0002-0430-9887

  ⨯